Arcus Biosciences, Inc. (RCUS) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US03969F1093
Arcus Biosciences, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 247.00 m USD |
| Operating income | -386.00 m USD |
| EBIT | -345.00 m USD |
| Net income | -353.00 m USD |
| Diluted EPS – continuing operations | -3.29 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Arcus Biosciences, Inc.
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers; and Zimberelimab, an anti-PD-1 antibody. It also develops Quemliclustat, a small molecule inhibitor that targets the CD73 enzyme in the ATP-adenosine pathway, which is in phase 3 and phase 1/1b clinical trial for lung and pancreatic cancer. In addition, the company develops AB598, a CD39 antibody, which is in phase 1/1b clinical study for gastrointestinal cancer and AB801, an AXL inhibitor, which is in Phase 1b clinical trial for lung cancer. It has clinical collaboration with AstraZeneca for the Phase 3 PACIFIC-8 trial evaluating domvanalimab and durvalumab in Stage 3 NSCLC and for a Phase 1/1b study evaluating casdatifan and volrustomig in IO-naive patients with ccRCC; BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases; and Bristol-Myers Squibb Company to develop a novel treatment regimen that delivers tumor control in kidney cancer. Arcus Biosciences, Inc. was incorporated in 2015 and is based in Hayward, California.
More stocks
- EZCORP INC (EZPW)
- Under Armour, Inc. (UAA)
- Chagee Holdings Limited American Depositary Shares (CHA)
- Brighthouse Financial, Inc. (BHF)
- Nippon Electric Glass Co Ltd (5214.T)
- Rocket Internet (RKET.HM)
- DXP ENTERPRISES INC (DXPE)
- Hammerson PLC (HMSO.L)
- Watches of Switzerland Group PLC (WOSG.L)
- Hamilton Insurance Group, Ltd. (HG)
- Home Product Center Public Company Limited (HMPRO.BK)
- Beijing Ultrapower Software (300002.SZ)
Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.